Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$241.1M
Avg Funding
$9.6M
Global Reach
8
countries

Top Cities for Biopharma

Mclean
San Francisco
Montefiascone
Angoulême
New Suffolk
Singapore

Recently Funded Companies

Export
Mclean, United States

Response Pharmaceuticals is a biotechnology and pharmaceutical company.

$3.9M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.

$20.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Montefiascone, Italy

GeneSys Bio's portable AI system detects pathogens and AMR in < 30 mins with >98% sensitivity, replacing slow lab tests and saving lives.

$107K raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Angoulême, France

Inside Therapeutics offers microfluidic-based systems for nanoparticle manufacturing, focusing on LNP-RNA vaccine development and oncology.

$1.4M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

New Suffolk, United States

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

$1.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Singapore, Singapore

Founded in 2022, we are a spin-out from Singapore-MIT Alliance for Research and Technology (SMART) and NTU Lee.

$1.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Edinburgh, United Kingdom

ŌGI Bio is a Biotechnology Research company.

$826K raised
Jun 2024

Founder Contacts

41,000+ verified contacts

San Diego, United States

The Ultimate Interface for Scientists, starting with molecular data. Collaborative AI+XR solution for scientific discovery

$1.2M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Mereo is a new UK-based speciality biopharmaceutical company.

$50.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Intolerant Antibodies is a biopharmaceuticals and healthcare company.

$1.1M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

$2.0M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Nelson, New Zealand

Broad-spectrum antiviral drug development

$8.7M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

$51.4M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Liverpool, United Kingdom

Incanthera develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific

$3.3M raised
Jun 2024

Founder Contacts

41,000+ verified contacts

Baltimore, United States

Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.

$137K raised
May 2024

Founder Contacts

41,000+ verified contacts

Fishers, United States

INCOG BioPharma services include injectable drug product formulation, analytical method, process scale up, and formulation.

$42.9M raised
May 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Intelligent bioprocess platform

$8.2M raised
May 2024

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.

$26.0M raised
May 2024

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

$712K raised
May 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.

$2.6M raised
May 2024

Founder Contacts

41,000+ verified contacts

Montreal, Canada

AI-powered image recognition technology for rapid pathogen identification.

$1.1M raised
May 2024

Founder Contacts

41,000+ verified contacts

Vancouver, Canada

Derm-Biome Pharmaceuticals is a biopharmaceutical company focused on developing treatments for skin diseases and conditions. .

$328K raised
May 2024

Founder Contacts

41,000+ verified contacts

Kyoto, Japan

AceRNA Technologies is a biotech startup that develops patient-centric genetic therapies with RNA switch technology for drug discovery.

$6.2M raised
May 2024

Founder Contacts

41,000+ verified contacts

Birmingham, United States

Acclinate leverages sustained engagement and AI-driven insights to empower communities to take actions for better health.

$7.0M raised
May 2024

Founder Contacts

41,000+ verified contacts

Foster City, United States

Cache is advancing personalized medicine and digital data storage by making storage and access to biomolecules widely accessible.

May 2024

Founder Contacts

41,000+ verified contacts

Showing 551 to 575 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$9.6M
Total Funding Tracked
$241.1M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.London
2 companies$52.6M
2.Philadelphia
2 companies$53.4M
3.Cambridge
2 companies$34.2M
4.Mclean
1 companies$3.9M
5.San Francisco
1 companies$20.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked